Difference between revisions of "Team:Virginia/References"

Line 54: Line 54:
 
<p><span class="ptitle"></span>
 
<p><span class="ptitle"></span>
 
<ul id="reflist">
 
<ul id="reflist">
−
<li>
+
<li>Mandell, Daniel J., Marc J. Lajoie, Michael T. Mee, Ryo Takeuchi, Gleb Kuznetsov, Julie E. Norville, Christopher J. Gregg, Barry L. Stoddard, and George M. Church. "Corrigendum: Biocontainment of Genetically Modified Organisms by Synthetic Protein Design." Nature 527.7577 (2015): 264. Web.</li>
−
Mandell, Daniel J., Marc J. Lajoie, Michael T. Mee, Ryo Takeuchi, Gleb Kuznetsov, Julie E. Norville, Christopher J. Gregg, Barry L. Stoddard, and George M. Church.  
+
<li> Nanduri, V.B., Goldberg, S., Johnston, R., and Patel, R.N. (2004). Cloning and expression of a novel enantioselective N-carbobenzyloxy-cleaving enzyme. Enzyme and Microbial Technology 34, 304–312.</li>
−
"Corrigendum: Biocontainment of Genetically Modified Organisms by Synthetic Protein Design." Nature 527.7577 (2015): 264. Web.
+
<li>Shlomiya Bar-Yam, Jennifer Byers-Corbin, Rocco Casagrande, Florentine Eichler, Allen Lin, Martin Oesterreicher, Pernilla Regardh, R. Donald Turlington, and Kenneth A. Oye (2012). The Regulation of Synthetic Biology (SynBERC).</li>
−
<li> Nanduri, V.B., Goldberg, S., Johnston, R., and Patel, R.N. (2004). Cloning and expression of a novel enantioselective N-carbobenzyloxy-cleaving enzyme. Enzyme and Microbial Technology 34, 304–312.
+
 
−
</li>
+
<li>Department of Health and Human Services (2016). NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (National Institute of Health).
 +
</li>
 +
<li>Sarah R. Carter, Ph.D., Michael Rodemeyer, J.D., Michele S. Garfinkel, Ph.D., and Robert M. Friedman, Ph.D. (2014). Synthetic Biology and the US Biotechnology Regulatory System: Challenges and Option (J. Craig Venter Institute).
 +
</li>
 +
 
 
</ul>
 
</ul>
 
</p>
 
</p>

Revision as of 22:52, 16 October 2016

← Safety

REFERENCES

  • Mandell, Daniel J., Marc J. Lajoie, Michael T. Mee, Ryo Takeuchi, Gleb Kuznetsov, Julie E. Norville, Christopher J. Gregg, Barry L. Stoddard, and George M. Church. "Corrigendum: Biocontainment of Genetically Modified Organisms by Synthetic Protein Design." Nature 527.7577 (2015): 264. Web.
  • Nanduri, V.B., Goldberg, S., Johnston, R., and Patel, R.N. (2004). Cloning and expression of a novel enantioselective N-carbobenzyloxy-cleaving enzyme. Enzyme and Microbial Technology 34, 304–312.
  • Shlomiya Bar-Yam, Jennifer Byers-Corbin, Rocco Casagrande, Florentine Eichler, Allen Lin, Martin Oesterreicher, Pernilla Regardh, R. Donald Turlington, and Kenneth A. Oye (2012). The Regulation of Synthetic Biology (SynBERC).
  • Department of Health and Human Services (2016). NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (National Institute of Health).
  • Sarah R. Carter, Ph.D., Michael Rodemeyer, J.D., Michele S. Garfinkel, Ph.D., and Robert M. Friedman, Ph.D. (2014). Synthetic Biology and the US Biotechnology Regulatory System: Challenges and Option (J. Craig Venter Institute).